Markets have rallied since June, and investors seem to be seeking out solid companies based on research and economics instead of knee-jerk reactions to trends More
-
-
Sponsored By:
-
Sponsored By:
CLX
3 ETFs Breaking Away From the Pack
Which sectors are positioned as better breakout leaders? The answer points to three ETFs that could make much stronger moves than others. More
Should I Buy Clorox? 3 Pros, 3 Cons
Clorox put out a positive quarterly result, but is it a sign that investors should come on in? The question is a matter of comparison. More
Clorox Continues to Clean Up
Clorox continued to provide strong results, notching its sixth consecutive quarter of sales growth and edging out analyst estimates on earnings per share More
Uncle Ben Stays Mum: Wednesday’s IP Market Recap
Stocks were mostly muted on the Fed's non-news. Up next: Word from Bernanke's counterparts at the European Central Bank. More
Should I Buy Procter & Gamble? 3 Pros, 3 Cons
The consumer-products giant face plenty of challenges ahead, but William Ackman's involvement should put a floor under the stock. More
Hidden Valley Gets A+ for Gluten-Free Effort
Hidden Valley did its homework before updating the labels on many of its salad dressings to include the term 'gluten-free.' More
